Citation: Gd. Shelton et al., Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis, VET IMMUNOL, 78(1), 2001, pp. 97-105
Authors:
Romi, F
Skeie, GO
Vedeler, C
Aarli, JA
Zorzato, F
Gilhus, NE
Citation: F. Romi et al., Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis - A study of IgG subclasses and clinical correlations, J NEUROIMM, 111(1-2), 2000, pp. 169-176
Authors:
Mygland, A
Vincent, A
Newsom-Davis, J
Kaminski, H
Zorzato, F
Agius, M
Gilhus, NE
Aarli, JA
Citation: A. Mygland et al., Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia, ARCH NEUROL, 57(4), 2000, pp. 527-531
Citation: F. Romi et al., The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies, ARCH NEUROL, 57(11), 2000, pp. 1596-1600
Authors:
Somnier, FE
Skeie, GO
Aarli, JA
Trojaborg, W
Citation: Fe. Somnier et al., EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis, EUR J NEUR, 6(5), 1999, pp. 555-563